Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carisma Therapeutics
Biotech
Carisma lightens load to stretch cash runway into Q3 2025
Carisma is leaving 37% of staffers and a clinical asset on the roadside in hopes of stretching its cash runway into the third quarter of 2025.
Gabrielle Masson
Apr 1, 2024 11:08pm
SNAP, CAR-M and BiTE: New immunotherapy approaches at SITC
Nov 6, 2023 11:36am
After sealing reverse merger, Carisma aims for cancer wins
Mar 21, 2023 11:20am
Sesen Bio makes up with investors in time for Valentine’s Day
Feb 14, 2023 11:00am
Sesen no more: Biotech merges with Carisma
Sep 21, 2022 10:40am
Moderna strikes $45M deal with macrophage biotech Carisma
Jan 10, 2022 10:25am